First, as the clinical data of patients with lung cancer were retrospectively collected, given the general distribution in the lung cancer population, there were imbalances in the subgroups concerning pulmonary function, type of initial therapy, the purposes of KL-6 testing, and ILD subtypes (Table 1). This evidence concerns the gene MUC1 and interstitial lung disease.